Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLU-v in H1N1 Influenza Healthy Human Challenge
NCT03180801Phase 2Completed
- Sponsor
- SEEK
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by SEEK. Started Aug 2016; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03180801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180801.